Business News | Stock and Share Market News

Business News | Stock and Share Market News






















The decision comes a day after members of ICMR’s National Task Force said they were not in favour of continuing the plasma therapy on COVID-19 patients due to its ineffectiveness and inappropriate use in several cases..


Plasma therapy dropped from clinical management guidelines for COVID-19 patients




Name Price Change % Chg
No Bond details available.

Forum

Forum

YOUR OPINION


COMMENTS

Thank You for Voting